DCH Auriga
DCH Auriga is an Asia-based integrated market management provider specializing exclusively in healthcare, offering end-to-end regulatory, commercial, supply chain, and distribution services across 10 Asian economies for pharmaceutical and medical device principals.
- Company typePrivate
- Founded2017
- HeadquartersKwai Tsing, Hong Kong SAR China
- Headcount251–500
- GTM typeB2B
- OfferingServices
What DCH Auriga does
DCH Auriga is an Asia-based integrated market management provider specializing exclusively in the healthcare sector. The company offers three core solution categories: Market Management Solutions (regulatory and import support, marketing, sales, account management, merchandising, and home health delivery), Supply Chain Solutions (warehousing, cold chain, transport, pick and pack, value-added services, and reverse logistics), and Products & Networks (distribution of pharmaceuticals, medical devices, diagnostics, OTC, nutrition, surgical equipment, consumables, and consumer health products). Operations span 10 Asian economies — Hong Kong, Macau, mainland China, Singapore, Malaysia, Brunei, Indonesia, Thailand, the Philippines, and Vietnam — served through wholly-owned local subsidiaries and dedicated distribution centers, including Wyler Centre 1, Hong Kong's only building dedicated entirely to healthcare warehousing and distribution.
The company's technology stack centers on a digital supply chain platform featuring JDA Warehouse Management System integrated with ERP (deployed in Singapore and Hong Kong), RFID tracking, real-time temperature monitoring with digital temp-tags, and qualified cold chain capabilities across multiple temperature bands (2-8°C, less than -18°C, less than -25°C, 0-4°C). It maintains sector-specific quality certifications including ISO 13485:2016, ISO 9001, GDP, and GDPMD across multiple jurisdictions.
DCH Auriga generates revenue primarily through transaction-fee distribution and logistics services for pharmaceutical and medical device principals, supplemented by professional-services revenue from commercial market management engagements. Its named customer base includes Pfizer, Johnson & Johnson, Sanofi, Gilead, MSD, GE Healthcare, Baxter, and Fosun Pharma, with over 500 brands distributed across more than 10,000 points of sale. The company is a wholly-owned subsidiary of Dah Chong Hong Holdings (CITIC Pacific/CITIC Limited group).
DCH Auriga firmographics
Firmographics- Name
- DCH Auriga
- Legal name
- DCH Auriga (Hong Kong) Ltd
- Website
- https://dchauriga.com
- Company type
- Private
- Founded year
- 2017
- Operating status
- Operating
- Headcount range
- 251–500 employees
- Short description
- DCH Auriga is an Asia-based integrated market management provider specializing exclusively in healthcare, offering end-to-end regulatory, commercial, supply chain, and distribution services across 10 Asian economies for pharmaceutical and medical device principals.
- Ownership category
- akta.pro rank
DCH Auriga industry classification
Industry- Product category
- Healthcare Distribution Services
- NAICS
- Refrigerated Warehousing and Storage (493120), Drugs and Druggists' Sundries Merchant Wholesalers (42421), General Warehousing and Storage (493110), Warehousing and Storage (493)
- SIC
- Wholesale-Medical, Dental & Hospital Equipment & Supplies (5047), Public Warehousing & Storage (4220), Wholesale-Professional & Commercial Equipment & Supplies (5040)
- akta.pro primary industry
- Pharmaceutical & Healthcare Distribution Centers (GDP-compliant) (TLALAEAE)
- akta.pro secondary industries
- Temperature-Controlled Distribution Centers (DCs) (AFAOAFAE), Retail & Wholesale Distribution Centers (Dry DCs) (TLALAAAD), Reverse Logistics & Returns Distribution Centers (TLALAEAM)
Keywords
Where DCH Auriga is headquartered
LocationHeadquarters
- HQ city
- Kwai Tsing
- HQ country
- Hong Kong SAR China
- HQ region
- Asia
Offices10 records
Markets served
DCH Auriga business model
Business model- GTM type
- B2B
- Offering type
- Services
- Cost components
- Operations, Personnel, Infrastructure, Technology or R&D, Marketing or Sales, Supply Chain
Revenue model
- Distribution and Logistics Services: Core revenue from managing end-to-end supply chains for healthcare products across Asia, including warehousing, transport, and delivery services.
- Market Management Solutions: Commercial services including regulatory compliance, marketing, sales, account management, and consultation services for healthcare principals.
- Product Distribution: Distribution of pharmaceutical, medical device, diagnostics, OTC, nutrition, surgical equipment, consumables, and health and beauty products across their network.
Go-to-market motion2 records
Distribution channels4 records
Marketing channels6 records
DCH Auriga product offering
Product offeringCore offering
DCH Auriga provides end-to-end integrated market management and supply chain solutions for the healthcare industry across 10 Asian economies. The company combines commercial services—including regulatory compliance, marketing, sales, and account management—with logistics services such as warehousing, cold chain storage, transport, and home delivery for pharmaceutical, medical device, diagnostics, OTC, nutrition, surgical equipment, consumables, and consumer health products from world-leading principals.
Product overview
DCH Auriga is an Asia-based integrated market management provider specializing in healthcare. The company offers three core solution categories: Market Management Solutions (covering regulatory compliance, marketing, sales, and home health services), Supply Chain Solutions (including warehousing, cold chain, transport, and reverse logistics), and Products & Networks (spanning pharmaceuticals, medical devices, diagnostics, and consumer health products). The company operates as a unified platform serving healthcare companies across 10 Asian economies, combining commercial and logistics services to enable partners to access market opportunities in Asia.
Differentiator
Problem solved
Functional benefit
Products and services
- Market Management Solutions Comprehensive commercial services including consultation and market intelligence, regulatory and import support, ethical advocacy, consumer marketing, digital and omni-channel services, sales and account services, merchandising, and home health delivery for healthcare principals expanding across Asia.
- Supply Chain Solutions End-to-end supply chain management including customs management, warehouse management, pick and pack operations, value added services (relabeling, repacking, kitting), cold chain solutions, transport and delivery, reverse logistics, and distributor transition management for healthcare products.
- Products & Networks Product marketing and distribution expertise spanning pharmaceuticals, medical devices, diagnostics, OTC, nutrition, surgical equipment, consumables, and health and beauty products, with access to professional healthcare networks including government hospitals, private hospitals, clinics, pharmacies, and retailers across Asia.
Quantifiable outcome
- Distribution across 10 Asian economies serving more than 500 brands at over 10,000 points of sale
- +1 more outcomes
Companies that use DCH Auriga
Customer profileNamed customers9 records
Segments4 records
Ideal customer profiles3 records
DCH Auriga technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature5 records
DCH Auriga partnerships and signals
Strategic signalPartnerships
Four partnerships are on record, tiered strategic and core.
- Hong Kong Integrated Oncology Centre (HKIOC)strategicStrategic cooperation between DCH Auriga and HKIOC to support Zhongshan Chenxinghai Hospital in offering Hong Kong-approved medical treatments to Greater Bay Area patients, supporting a National State Council initiative.
- Zhongshan Chenxinghai HospitalstrategicPartnership under the GBA healthcare initiative where DCH Auriga and HKIOC support the hospital to offer Hong Kong-approved medical treatments to Greater Bay Area patients.
- Fosun PharmacoreDCH Auriga was selected as the exclusive logistics partner for the distribution of Fosun Pharma-BioNTech COVID-19 vaccine (COMIRNATY) in Hong Kong. They managed the storage and delivery of the vaccine.
- BaxterstrategicDCH Auriga supports Baxter with home delivery for chronic care including renal dialysis solutions, appointed as sole distributor for renal dialysis solution in Hong Kong in 2015.
Scale indicators5 records
Recent moves14 records
Expansion highlights5 records
DCH Auriga competitors and assessment
Company assessmentMarket position
Competitive moat6 records
Key highlights7 records
Customer concentration
DCH Auriga social profiles
Digital presenceDCH Auriga compliance and trust
Trust signalCompliance10 records
DCH Auriga financial estimates
Financial estimateRevenue estimate
Valuation estimate
DCH Auriga leadership team
Management profileNumber of profiles
DCH Auriga subsidiaries and ownership
Company hierarchySubsidiaries9 records
DCH Auriga funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
DCH Auriga M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about DCH Auriga
What does DCH Auriga do?
DCH Auriga provides end-to-end integrated market management and supply chain solutions for the healthcare industry across 10 Asian economies. The company combines commercial services—including regulatory compliance, marketing, sales, and account management—with logistics services such as warehousing, cold chain storage, transport, and home delivery for pharmaceutical, medical device, diagnostics, OTC, nutrition, surgical equipment, consumables, and consumer health products from world-leading principals.
Is DCH Auriga a public or private company?
DCH Auriga is a private company. It is classified as corporate owned and is currently operating.
When was DCH Auriga founded?
DCH Auriga was founded in 2017. It employs 251 to 500 people.
Where is DCH Auriga based?
DCH Auriga is headquartered in Kwai Tsing, Hong Kong SAR China, in the Asia region.
How does DCH Auriga make money?
Three revenue lines are on record. Distribution and Logistics Services are the primary driver. The others are market Management Solutions and product Distribution.
Does DCH Auriga have an API?
No public API is recorded for DCH Auriga.
What industry is DCH Auriga in?
DCH Auriga's product category is Healthcare Distribution Services. Its primary akta.pro industry code is TLALAEAE, Pharmaceutical & Healthcare Distribution Centers (GDP-compliant), with a secondary code of AFAOAFAE, Temperature-Controlled Distribution Centers (DCs). Its NAICS code is 493120 and its SIC code is 5047.